Diagnosis of Pulmonary Fibrosis is extremely challenging as it requires integration of clinical, radiologic and histopathologic information.
Position statements for the diagnosis and management of Pulmonary Fibrosis in Australia have been developed in partnership with the Thoracic Society of Australia and New Zealand (TSANZ) and Lung Foundation Australia (LFA).
Using our expertise in research translation we have used theoretically-informed strategies to implement and evaluate uptake of the information provided in these position statements for evidence-based diagnosis and management of PF in Australia.
We have conducted an international Delphi survey to determine the essential features of Multidisciplinary Meetings (MDM) for diagnosing interstitial lung disease (Teoh et al., 2021). The team have also described the benefits of a virtual interstitial lung disease MDM in the face of COVID-19 (Mackintosh et al., 2021) and barriers and facilitators to best care for IPF in Australia (Tikellis et al., 2021).
The interstitial lung disease MDM toolkit has been developed by A/Prof Ian Glaspole and Prof Anne Holland in collaboration with the Lung Foundation Australia. The toolkit contains resources designed to aid in the presentation and discussion of cases presented at ILD multidisciplinary meetings. The toolkit resources are available to download now and are available here.
The resources can be downloaded and saved for local use or used as templates to develop individualised documents.